Discover a study revealing how chemotherapy-induced tumour pyroptosis reprograms fibroblasts, promoting chemoresistance in ...

The first bladder transplant in a living patient is the successful result of years of research and surgical innovation.

Building on preclinical work (Hong X, Adv Sci, 2023) demonstrating the antitumor activity of disitamab vedotin (RC48) in HER2-expressing orthotopic bladder cancer models, Dr. Chen and colleagues ...

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from ...

This gall bladder operation was far more complex, with the robot surgeon — powered by a two-tier AI system — trained on 17 hours of video encompassing 16,000 motions.

The Funding Continuity Grant was created to ensure that high-quality bladder cancer research—previously peer-reviewed, approved and funded—can move forward without interruption. It comes in addition ...

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best hot stocks to buy according to Wall Street analysts. In mid-June, UroGen Pharma announced that the US FDA had approved ZUSDURI (mitomycin) for ...

ASCO 2025 interim analysis from the JAVELIN Bladder Medley phase 2 trial, avelumab + sacituzumab govitecan, avelumab monotherapy, first-line maintenance treatment in patients with advanced urothelial ...

Innovative treatments for non–muscle-invasive bladder cancer emerge, focusing on bladder preservation and improved outcomes with novel therapies and active surveillance strategies.